Depomed (DEPO) Misses Q1 EPS by 7c; Guides Below
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall as megacap tech drags; Iran developments watched
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
DepoMed Inc (DEPO) PT Lowered to $13 at RBC Capital; Magnitude of Reset was a Suprise
May 10, 2017 6:24 AM EDTRBC Capital lowered its price target on DepoMed Inc (NASDAQ: DEPO) to $13.00 (from $19.00) while maintaining a Sector Perform rating following a sizable reset on outlook.
Analyst Randall Stanicky said the reset is not a surprise given new CEO but magnitude... More
Piper Jaffray Upgrades DepoMed Inc (DEPO) to Neutral
May 10, 2017 4:54 AM EDTPiper Jaffray upgraded DepoMed Inc (NASDAQ: DEPO) from Underweight to Neutral with a price target of $10.00 (from $11.00).
Analyst David Amsellem believes the company multiple is reflective of the company's "relatively murky prospects" when it comes to LT growth opportunities.
FY 2017 EPS estimate... More
